肠易激综合征整合医疗中的行为与饮食疗法
肠易激综合征(IBS)是常见症状性疾病,对生活质量有负面影响并每年耗费医疗系统数十亿美元。管理曾聚焦于非处方药和处方药,但仅不到半数患者症状缓解。行为干预(胃肠道聚焦认知行为疗法和肠道导向催眠疗法)与饮食调整(低FODMAP饮食最常推荐且证据最充分)可有效治疗IBS。管理应采用整合医疗模式,将行为干预、饮食调整和药物视为同等伙伴。
要点
- 行为干预包括胃肠道聚焦认知行为疗法和肠道导向催眠疗法,可调节肠脑互动。
- 低FODMAP饮食是医疗提供者最常推荐且证据最充分的饮食干预,分限制、重新引入和个性化三阶段。
- IBS管理应采用整合医疗模式,将行为干预、饮食调整和药物视为同等伙伴。
核心结论
- IBS管理应采用整合医疗模式,将行为干预、饮食调整和药物视为同等伙伴,此方法为管理IBS患者提供最大成功可能性。
研究设计与样本
- 原文为综述,未报告系统检索范围。
主要发现
- 行为干预包括胃肠道聚焦认知行为疗法和肠道导向催眠疗法,旨在改变肠脑互动。
- 低FODMAP饮食是医疗提供者最常推荐且证据最充分的饮食干预,包含限制、重新引入和个性化3个阶段。
- 药物仅使不到半数患者症状缓解。
临床怎么用
- IBS管理应采用整合医疗模式,将行为干预、饮食调整和药物作为同等伙伴考虑。
- 选择低FODMAP饮食的患者应了解其限制、重新引入和个性化3个阶段。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Irritable bowel syndrome (IBS) is a common, symptom-based condition that has negative effects on quality of life and costs health care systems billions of dollars each year. Until recently, management of IBS has focused on over-the-counter and prescription medications that reduce symptoms in fewer than one-half of patients. Patients have increasingly sought natural solutions for their IBS symptoms. However, behavioral techniques and dietary modifications can be effective in treatment of IBS. Behavioral interventions include gastrointestinal-focused cognitive behavioral therapy and gut-directed hypnotherapy to modify interactions between the gut and the brain. In this pathway, benign sensations from the gut induce maladaptive cognitive or affective processes that amplify symptom perception. Symptoms occur in response to cognitive and affective factors that trigger fear of symptoms or lack of acceptance of disease, or from stressors in the external environment. Among the many dietary interventions used to treat patients with IBS, a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols is the most commonly recommended by health care providers and has the most evidence for efficacy. Patient with IBS who choose to follow a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols should be aware of its 3 phases: restriction, reintroduction, and personalization. Management of IBS should include an integrated care model in which behavioral interventions, dietary modification, and medications are considered as equal partners. This approach offers the greatest likelihood for success in management of patients with IBS.
引用
- Chey WD, Keefer L, Whelan K, et al. Behavioral and Diet Therapies in Integrated Care for Patients With Irritable Bowel Syndrome. Gastroenterology. 2020. PMID: 33091411. doi:10.1053/j.gastro.2020.06.099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。